Podcast
Questions and Answers
How does inclisiran reduce LDL-C levels?
How does inclisiran reduce LDL-C levels?
- By targeting PCSK9 mRNA with an siRNA (correct)
- By promoting PCSK9 binding to the LDLR
- By blocking PCSK9 production at the translational stage
- By inhibiting PCSK9 auto-catalytic processing
Which phase of PCSK9's life cycle is targeted by inclisiran?
Which phase of PCSK9's life cycle is targeted by inclisiran?
- Inhibition of LDLR binding
- Inhibition of PCSK9 production (correct)
- Inhibition of auto-catalytic processing
- All of the above
What is the main effect of stopping PCSK9 auto-catalytic processing?
What is the main effect of stopping PCSK9 auto-catalytic processing?
- Reduction in PCSK9 plasma concentrations
- Lowering risk of cardiovascular disease
- Increased cell secretion and maturation
- Elevated LDL-C levels (correct)
Which method frees up more receptors to be recycled to the cell surface for LDL-C elimination?
Which method frees up more receptors to be recycled to the cell surface for LDL-C elimination?
What is the primary role of inclisiran in individuals with primary hypercholesterolemia?
What is the primary role of inclisiran in individuals with primary hypercholesterolemia?
What distinguishes inclisiran's mechanism of action from other PCSK9 inhibitors?
What distinguishes inclisiran's mechanism of action from other PCSK9 inhibitors?